DNA repair in the trinucleotide repeat disorders.

Area of Science:

• Neurogenetics
• Molecular Biology
• Genomic Medicine

Background:

• Inherited trinucleotide repeat disorders are severe neurological conditions with limited treatment options.
• Phenotypic variation, including anticipation, suggests additional genetic modifiers beyond repeat length.
• Existing research points to DNA damage and repair pathways as key factors influencing disease onset.

Purpose of the Study:

• To investigate the common genetic architecture of trinucleotide repeat disorders.
• To identify genetic modifiers affecting the age of onset in these diseases.
• To explore potential therapeutic targets within DNA repair pathways.

Main Methods:

• Genome-wide association studies (GWAS) to identify genetic modifiers.
• Sequencing approaches to pinpoint phenotype-modifying variants.
• Cell biology analyses to elucidate molecular mechanisms.

Main Results:

• Genetic modifiers of age at onset identified in Huntington's disease and spinocerebellar ataxias.
• Association found between DNA damage-response/repair pathways and disease onset.
• Somatic expansion of CAG tracts correlates with earlier onset in mouse models.

Conclusions:

• A common genetic mechanism likely modulates age at onset across polyglutamine and other repeat expansion disorders.
• DNA damage response genes represent potential therapeutic targets for multiple trinucleotide repeat disorders.
• Further genetic analysis and mechanistic studies are needed to translate findings into treatments.